Immunotech Biopharm Ltd. has announced that Dr. Wang Yu has resigned from her roles as executive director, chief executive officer, and chief technology officer, effective June 25, 2025. Mr. Zhang Jian, the senior vice president, has been appointed as the Acting CEO to manage the day-to-day operations of the company. The board has denied any merit to recent allegations made by Dr. Wang and reports no disagreements with other directors.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunotech Biopharm Ltd. published the original content used to generate this news brief on May 30, 2025, and is solely responsible for the information contained therein.